Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment

Appl Biochem Biotechnol. 2024 Mar;196(3):1685-1711. doi: 10.1007/s12010-023-04597-5. Epub 2023 Jul 4.

Abstract

Conventional cancer therapies with chemodrugs suffer from various disadvantages, such as irreversible side effects on the skin, heart, liver, and nerves with even fatal consequences. RNA-based therapeutic is a novel technology which offers great potential as non-toxic, non-infectious, and well-tolerable platform. Herein, we introduce different RNA-based platforms with a special focus on siRNA, miRNA, and mRNA applications in cancer treatment in order to better understand the details of their therapeutic effects. Of note, the co-delivery of RNAs with other distinct RNA or drugs has provided safe, efficient, and novel treatment modalities for cancer treatment.

Keywords: Cancer-therapy; Immunotherapy; Oligonucleotide; mRNA; miRNA; siRNA.

Publication types

  • Review

MeSH terms

  • MicroRNAs* / genetics
  • MicroRNAs* / therapeutic use
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Oligonucleotides / genetics
  • Oligonucleotides / therapeutic use
  • RNA, Double-Stranded
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / therapeutic use

Substances

  • Oligonucleotides
  • MicroRNAs
  • RNA, Small Interfering
  • RNA, Double-Stranded